TY - JOUR
T1 - Optical Coherence Tomography in Cardiac Allograft Vasculopathy
T2 - State-of-the-Art Review
AU - Acharya, Deepak
AU - Loyaga-Rendon, Renzo Y.
AU - Chatterjee, Arka
AU - Rajapreyar, Indranee
AU - Lee, Kwan
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Cardiac allograft vasculopathy (CAV) is a challenging complication of heart transplantation. CAV pathophysiology is incompletely understood, standard screening modalities such as angiography have significant limitations, and currently available therapies have only modest efficacy in preventing progression. Optical coherence tomography is a light-based technique that provides microscopic level catheter-based intravascular imaging and has dramatically expanded our understanding of CAV, demonstrating it to be a complex, heterogeneous, and dynamic process. This review covers characteristics and uses of optical coherence tomography, including vessel characterization, serial use to assess progression of disease, guiding percutaneous intervention, and monitoring response to CAV therapies. We also discuss the potential of optical coherence tomography in providing individualized assessment and enable customized CAV therapies, which may lead to improvements in long-term transplant outcomes.
AB - Cardiac allograft vasculopathy (CAV) is a challenging complication of heart transplantation. CAV pathophysiology is incompletely understood, standard screening modalities such as angiography have significant limitations, and currently available therapies have only modest efficacy in preventing progression. Optical coherence tomography is a light-based technique that provides microscopic level catheter-based intravascular imaging and has dramatically expanded our understanding of CAV, demonstrating it to be a complex, heterogeneous, and dynamic process. This review covers characteristics and uses of optical coherence tomography, including vessel characterization, serial use to assess progression of disease, guiding percutaneous intervention, and monitoring response to CAV therapies. We also discuss the potential of optical coherence tomography in providing individualized assessment and enable customized CAV therapies, which may lead to improvements in long-term transplant outcomes.
KW - catheter
KW - coronary angiography
KW - heart transplantation
UR - http://www.scopus.com/inward/record.url?scp=85115947367&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115947367&partnerID=8YFLogxK
U2 - 10.1161/CIRCHEARTFAILURE.121.008416
DO - 10.1161/CIRCHEARTFAILURE.121.008416
M3 - Review article
C2 - 34414769
AN - SCOPUS:85115947367
SN - 1941-3289
VL - 14
SP - E008416
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 9
ER -